focus -WSS

focus

author：leisure time 2025-10-01 16:41:34 - browse：44

1:43Traders work on the floor of the New York Stock Exchange on July 12, 2023 in New York City.Spencer Platt/Getty Images

As long-standing recession alarms continue to blare from some forecasters, investors don’t appear to hear them.

The S&P 500 this year, when excluding the ten largest companies, stands at single-digit gains.

Looking ahead, Agati and Moya said they expect the stock market to decline over the remainder of the year, ending 2023 with positive but modest returns. The full economic cooling-off effects of central bank rate hikes have yet to take hold, they said, adding that inflation may not return to normal levels as soon as investors hope.

"The rally will stall out here," Moya said.

MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

Stoltzfus, however, said there's a "good chance" the stock market will end the year higher than it currently stands.

"We have maintained a fairly bullish posture," he said. "Where the market is trading right now would suggest to us that it has further to go this year."

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Medicaid rebukes states for mistakenly disenrolling children

leisure time

WSS

HHS suspends federal funding for EcoHealth Alliance

Humana sues Biden admin over Medicare Advantage audit rule

NIH nominee Bertagnolli will get October confirmation hearing

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

The (many) problems with a new study criticizing cancer screening

What a koala virus tells us about the human genome

entertainment

focus

MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

Wikipedia

Cancer drug shortages should be causing more outrage

Snackable artificial intelligence, expert AI, and the pharma industry

Medicare proposal to cover medical devices draws a mixed reaction

Ethical issues complicate the benefits of medical crowdfunding

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The White House hikes tariffs on plastic syringes made in China

Psychedelics group wrestles with new pharma identity

How to fix cancer clinical trials' diversity problem

Malaria cases in Florida and Texas: Here’s what you need to know

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

AstraZeneca chief proposes a novel edit to the drug pricing bill

Hottest summer in 2,000 years puts focus on extreme heat, health

Weighted lottery helped low

'Make People Better': The CRISPR babies story you probably don't know

The White House hikes tariffs on plastic syringes made in China

Medicaid rebukes states for mistakenly disenrolling children

leisure time

hotspot

Wikipedia

hotspot